HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumio Ikegami Selected Research

3-N-oxalyl-L -2,3-diaminopropanoic acid

3/2010Hind-limb paraparesis in a rat model for neurolathyrism associated with apoptosis and an impaired vascular endothelial growth factor system in the spinal cord.
7/2004Partial involvement of group I metabotropic glutamate receptors in the neurotoxicity of 3-N-oxalyl-L-2,3-diaminopropanoic acid (L-beta-ODAP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumio Ikegami Research Topics

Disease

5Lathyrism
05/2014 - 04/2003
1Anxiety Disorders (Anxiety Disorder)
12/2012
1Motor Neuron Disease (Primary Lateral Sclerosis)
03/2011
1Hemorrhage
03/2010
1Paraparesis
03/2010
1Vomiting
05/2004
1Diarrhea
05/2004
1Hypersensitivity (Allergy)
05/2004
1Breast Neoplasms (Breast Cancer)
11/2002

Drug/Important Bio-Agent (IBA)

3oxalyldiaminopropionic acidIBA
05/2014 - 04/2003
2AcidsIBA
05/2014 - 07/2004
23-N-oxalyl-L -2,3-diaminopropanoic acidIBA
03/2010 - 07/2004
2Amino AcidsFDA Link
07/2004 - 04/2003
1AMPA Receptors (AMPA Receptor)IBA
05/2014
1Transient Receptor Potential ChannelsIBA
05/2014
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
05/2014
1Banxia Houpo TangIBA
12/2012
1Biotin (Vitamin H)FDA Link
03/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2010
1Proteins (Proteins, Gene)FDA Link
07/2004
12,3-diaminopropionic acidIBA
04/2003
11,1-diphenyl-2-picrylhydrazylIBA
11/2002

Therapy/Procedure

2Kampo Medicine (Kampo)
12/2012 - 05/2004